Cross-Border Virtual-Care Recovery Leader

The mandate

An internal review found that some consultations were routed using customer location captured at registration rather than location and licensed coverage at the time of care. Simultaneously, overnight clinician gaps and incomplete diagnostic follow-up created unresolved patient journeys across country partners. Two services were suspended and the regional operations chief resigned. The interim takes executive control of access and delivery recovery while clinicians, licensed entities and country authorities retain all professional decisions.

The appointment starts within two weeks and runs twelve months through country remediation, two licence-renewal cycles and selection of a permanent regional chief operating officer. The first twenty-one days protect affected journeys, establish real-time jurisdiction and capacity truth and stop unsupported routing. Months two through eight rebuild access, scheduling, partner and follow-up controls; the final quarter proves them through peak demand, outage and cross-country scenarios before a three-month successor overlap.

Handover is complete when the permanent executive has chaired eight regional care-delivery reviews, all suspended services have an authorised disposition, sampled journeys reconcile location, clinician eligibility, consultation, referral, diagnostic and follow-up evidence, and each country has a tested continuity plan. The successor receives licence dependencies, partner obligations, capacity models, unresolved patient and regulatory actions, system limitations and a ninety-day plan owned by permanent country operators.

The interim may suspend intake, constrain services by country or hour, reallocate non-clinical resources, reset operating workflows, replace temporary vendors within budget and require evidence before reopening. Entering or leaving a country, removing medical directors, altering clinical protocols, changing clinician contracts, settling regulator matters, approving patient compensation outside policy or spending above THB100 million needs chief-executive, committee or licensed-entity approval. Clinicians and authorised officers retain treatment, prescribing, referral and licence judgments.

Clinical guideline design, diagnosis, individual patient remediation decisions, product-platform replacement, payer pricing and new-country expansion are outside scope. The interim will not infer patient location from stale profiles, hide unresolved follow-up, relax clinician eligibility or use shorter consultations as capacity recovery. Work concerns lawful routing, dependable service operations and transparent closure across the existing regional footprint; the independent review of prior conduct remains separate.

Why this seat is open

A control review exposed country-routing and follow-up failures serious enough to suspend services and remove confidence in regional operations leadership. The network must protect patients and respond to local authorities before a conventional search can conclude. The board needs a leader who has managed cross-border care operations, can enforce restricted service honestly and can transfer control without weakening licensed clinical accountability.

What you will own

• Reconcile patient location, service request, clinician eligibility, capacity, consultation, referral, diagnostic and follow-up events by country.
• Decide intake and operating restrictions within delegation against verified jurisdiction, coverage, demand and continuity evidence.
• Establish real-time routing, escalation and service-suspension controls that fail safely when location or licence state is uncertain.
• Reset clinician scheduling and partner capacity around specialty, language, jurisdiction, availability and protected breaks.
• Close regulator and patient-service actions through sampled journey evidence and accountable licensed entities.
• Exercise demand surge, platform outage, clinician absence, location ambiguity and partner failure across all five markets.
• Induct the permanent executive through eight reviews and transfer licences, partner risks and unresolved actions.

Candidate qualifications

• Has held executive operations authority across multi-country virtual care, telehealth or another regulated clinical-service network.
• Can evidence recovery of routing or continuity failures without crossing licensed clinical and country-entity boundaries.
• Understands clinician eligibility, patient location, scheduling, referral, diagnostics, pharmacy interfaces, privacy and follow-up.
• Has worked with multiple regulators and medical directors while keeping professional authority explicit.
• Can distinguish a completed consultation from a safely closed patient journey across external partners.
• Has transferred a regional healthcare recovery to permanent leadership after tested country and outage scenarios.

Non-negotiables

• Can start onsite in Bangkok within two weeks and complete monthly country reviews and quarterly field visits.
• Will not diagnose, prescribe, determine eligibility or override medical directors and licensed entities.
• Brings direct cross-border clinical-service authority; health-technology product leadership alone is insufficient.
• Will suspend routing where location, clinician authority or follow-up ownership cannot be verified.

1. 49 words maximum. Which patient-location or clinician-eligibility signal proved unsafe in a regional care service you led?
2. 49 words maximum. Confirm your earliest Bangkok start date and the countries where you held care-operations authority.
3. 49 words maximum. How have you closed a patient journey whose diagnostic or referral step sat with an external partner?